Reply to comments on "Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei"

Int J Clin Oncol. 2021 Mar;26(3):621. doi: 10.1007/s10147-021-01878-z. Epub 2021 Feb 6.

Sakura Hiraide^{1

2}, Keigo Komine^{2

3}, Masanobu Takahashi^{2

3}, Chikashi Ishioka^{4

5

6}

¹ Department of Clinical Oncology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Miyagi, Japan.
² Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
³ Department of Medical Oncology, Tohoku University Hospital, Aoba-ku, Sendai, Miyagi, Japan.
⁴ Department of Clinical Oncology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Miyagi, Japan. [email protected].
⁵ Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan. [email protected].
⁶ Department of Medical Oncology, Tohoku University Hospital, Aoba-ku, Sendai, Miyagi, Japan. [email protected].

No abstract available

Publication types